EXPERIENCE OF USE OF DTAP HEXAVACCINE AT THE VACCINAL PREVENTION UNIT FOR CHILDREN WITH HEALTH DEVIATIONS OF THE SCIENTIFIC CENTER OF CHILDREN’S HEALTH (FEDERAL STATE BUDGETARY SCIENTIFIC INSTITUTION)

Nowadays, parents are anxious about vaccination, as they fear both side effects of vaccines and large numbers of injections. The need in simultaneous administration of 4–5 injections became irrelevant due to development of combined vaccines; it resulted in improved vaccination coverage of children and higher trust of patients in vaccination in whole. The article presents experience of using a hexavaccine at the vaccinal prevention unit for children with health deviations of the Scientific Center of Children’s Health, as well as experience of concurrent immunization of children with a hexavaccine and a 10-valent vaccine against pneumococcal infection. The authors demonstrate that immunization with combined vaccines is safe for children, including premature infants, and reasonable when vaccination schedule has been broken. Moreover, it helps to reduce governmental expenses on immunization. Parents become more loyal vaccination due to the smaller number of injections and absence of adverse reactions.

1. Federal'nyi zakon o vnesenii izmeneniya v st. 9 Federal'nogo zakona «Ob immunoprofilaktike infektsionnykh boleznei» ot 21.12 2013 goda № 368-FZ [The Federal Law on Amending Article# 9 of the Federal Law "On Immunoprophylaxis of Infectious Diseases" dated 21.12 2013 № 368-FZ].

2. Vaktsina AaKDS-Gep V-IPV/Khib (Infanriks Geksa): obzor osnovnykh svoistv i perspektivy primeneniya v Rossiiskoi Federatsii [The vaccine DTaP-HepB-IPV / Hib (Infanrix Hexa): a review of the basic properties and application prospects in the Russian Federation]. Elsevier – Elsevier. 2013; 2: 1−16.

3. Product Monograph. Infanrix Hexa. Adsorbed Hib reconstituted with PEDIARIX. July 31, 2014.

4. Tichmann-Schumann I., Soemantri P., Behre U. et al. Immunogenicity and reactogenicity of four doses of diphtheria-tetanus-three-component acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b vaccine coadministered with 7-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2005 Jan; 24 (1): 70–7.

5. Knuf M., Habermehl P., Cimino C. et al. Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPV/Hib combination vaccine in healthy infants. Vaccine. 2006 May 29; 24 (22): 4727–36.

6. Chevallier B., Vesikari T., Brzostek J. et al. Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines. Pediatr Infect Dis J. 2009 Apr; 28 (4 Suppl.): S109–18.

7. Tatochenko V.K. Combination of vaccines in pediatric practice: when pertussis vaccination is a piece of joy! Pediatricheskaya farmakologiya – Pediatric pharmacology. 2012; 9 (4).